Document is current
Any future updates will be listed below
-
Authors
Lu, I-Na
Müller-Miny, Louisa
Krekeler, Carolin
Cheung, Phyllis Fung-Yi
Antonopoulou, Georgia
Jeibmann, Astrid
Schulte-Mecklenbeck, Andreas
Kerl, Kornelius
Call, Simon
Reicherts, Christian
Bleckmann, Annalen
Stelljes, Matthias
Lenz, Georg
Wiendl, Heinz
Meyer zu Hörste, Gerd
Grauer, Oliver M.
-
Funding
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (ME4050/12-1)
Interdisziplinäres Zentrum für Klinische Forschung, Universitätsklinikum Würzburg (MzH3/020/20)
Bundesministerium für Bildung und Forschung (Lipid Immune Neuropathy Consortium)
Universitätsklinikum Münster
- License Information
-
More Information
Article History
Received: 31 October 2024
Accepted: 16 June 2025
First Online: 30 June 2025
Change Date: 18 July 2025
Change Type: Update
Change Details: This article has been updated to amend the author name metadata.
Declarations
:
: Written informed consent was obtained from each patient prior to enrollment, following approval from the Ethics Committee of the Board of Physicians of the Region Westfalen-Lippe and the University of Münster (reference: 2010-262-f-S, 2015–522-f-S, 2021–198-f-S, 2024–345-f-S). Clinical data and CSF samples were collected in accordance with ethical guidelines and the principles of the Helsinki Declaration.
: Not applicable.
: INL, LMM, GMzH, and OG have filed a patent application concerning the diagnostic and therapeutic use of the CXCL16-CXCR6 axis in ICANS. The remaining authors declare no conflicts of interest.
